Join over 200 of your colleagues and register today!

 Stay on to attend Structure-Based Design (June 6 - 8)

Enabling rational drug design, furthering target identification, developing selective and also multitargeted kinase inhibitors are only a few of the pharmaceutical drug development strategies. Due to the growing research and emerging technology available, the limiting factor is not the amount of data that can be obtained but rather the quality of the data, validation and the associated costs. 

In its fifth year, CHI’s internationally recognized conference will discuss the challenges, opportunities and success stories evolving around protein kinase target inhibitors. A team of selected top experts will provide new insights in interactive discussions with the participants of the conference.

Join a team of top experts to discuss hot topics such as:

	Targeting Tumors
	Mechanisms of Resistance
	Therapeutic Targets
	Chemical Space
	Target Identification and Screening
	Assay Technologies
	Structure–Based Design